Circular RNAs as biomarkers and therapeutic targets for gastrointestinal cancers

Abstract

AbstractCircular RNAs are a class of noncoding RNAs with covalently linked 5′ and 3′ ends that arise from backsplicing events. The absence of a 5′ cap and a 3′ poly(A) tail makes circular RNAs relatively more stable than their linear counterparts. They are evolutionary conserved and tissue‐specific, and some show disease‐specific expression patterns. Although their biological functions remain largely unknown, circular RNAs have been shown to play regulatory roles by acting as microRNA sponges, regulators of RNA‐binding proteins, alternative splicing, and parental gene expression, and they could even encode proteins. Over the past few decades, circular RNAs have attracted wide attention in oncology owing to their implications in various tumors. Many circular RNAs have been characterized as key players in gastrointestinal cancers and influence cancer growth, progression, metastasis, and therapeutic resistance. Accumulating evidence reveals that their unique characteristics, coupled with their critical roles in tumorigenesis, make circular RNAs promising non‐invasive clinical biomarkers for gastrointestinal cancers. In the present review, we summarized the biological roles of the emerging circular RNAs and their potential as biomarkers and therapeutic targets, which may help better understand their clinical significance in the management of gastrointestinal cancers.